Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New injectable gel aims to boost skin glow and hydration

NCT ID NCT06547125

Symptom relief Sponsor: AbbVie Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed Phase 2/3 trial tested JUVÉDERM VOLITE, an injectable gel, to improve skin quality in 135 adults with fine lines and poor hydration. Participants either received the gel or no treatment, with the control group offered the gel after 2 months. The study measured aesthetic improvement and side effects over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
JUVÉDERM VOLITE injectable gel
What this could lead to
If it works, this could offer a non-surgical option to improve skin hydration and radiance, reducing fine lines and wrinkles.
What could go wrong
This is a small, completed trial with 135 participants in China, so results may not apply to everyone. As a cosmetic device, benefits are aesthetic and not life-changing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Participants

135 people

The number who actually took part.

Started

Jul 2024

Finished

Feb 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Fitzpatrick skin types II-IV * Participants' FACE-Q Satisfaction with Skin Scale scores must meet the following criteria: * Participants must have FACE-Q Satisfaction with Skin Scale sum of raw scores of 39 or less * Participants must score "Very Dissatisfied" or "Somewhat Dissatisfied" on the following two questions: * How hydrated your facial skin looks? * How radiant your facial skin looks? Exclusion Criteria: * Any skin condition in the face area that might not be suitable for injection * Uncontrolled systemic disease * History of anaphylactic shock, or allergy to lidocaine (or any amide-based anesthetics), hyaluronic acid (HA) products, or Streptococcal protein, or is planning to undergo desensitization therapy during the study * Active autoimmune disease * Tendency to develop hypertrophic scarring * Currently undergoing chemotherapy/radiotherapy * Is undergoing orthodontia before enrollment or is planning to undergo it during the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Skin quality deficit are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Skin quality deficit

Contacts and locations

Locations

  • China-Japan Friendship Hospital /ID# 260959

    Beijing, Beijing Municipality, 100029, China

  • Hangzhou First People's Hospital /ID# 260952

    Hangzhou, Zhejiang, 310003, China

  • Huashan Hospital, Fudan University /ID# 261582

    Shanghai, Shanghai Municipality, 200040, China

  • Nanjing Drum Tower Hospital /ID# 260950

    Nanjing, Jiangsu, 210008, China

  • Peking University First Hospital /ID# 260957

    Xicheng District, Beijing Municipality, 100034, China

  • Zhongda Hospital Southeast University /ID# 260951

    Nanjing, Jiangsu, 210009, China